Background: Interventional inflammatory bowel disease (IIBD) therapies can play a key role
in inflammatory bowel disease (IBD) related stricture/fistula/abscess deferring or avoiding …

Methods A systematic electronic literature search was performed (PROSPERO; no.
CRD42022308033). The primary outcomes were technical success, efficacy, complication …

Abstract Background and Aim Resection for Crohn's disease (CD) related strictures is
definitive but carries risk of morbidity, recurrence, and short bowel syndrome. On the …

Crohn's disease (CD) is a chronic inflammatory disease that leads to intestinal stricture in
nearly 35% of cases within 10 years of initial diagnosis. The unknown pathogenesis, lack of …

The pursuit of technological innovation and clinical excellence has propelled endoscopy to
the forefront of modern medicine, revolutionizing the diagnosis, treatment, and prevention of …

Background Crohn's disease (CD) is a chronic inflammatory condition of the gastrointestinal
tract. Current drugs are not effective for treating the primary fibrotic component of CD …

Self-expandable metal stent (SEMS) are widely utilized as a bridge to surgical intervention
and for palliative treatment of malignant bowel obstructions. The risk of complications …

While important knowledge gaps still exist, the application of endoscopic therapies in IBD is
more refined, especially within the management of colitis-associated dysplasia and …

Crohn's disease (CD) was initially described in 1932 by Dr Burrill Bernard Crohn as a “new
disease of the terminal ileum affecting mainly young adults, characterized by a subacute or …

摘要肠纤维化是炎症性肠病(inflammatory bowel disease, IBD) 的严重并发症,
然而目前尚未找到针对肠纤维化的治疗方案. ω⁃ 3 PUFAs 在其他器官中的抗纤维化作用已受到 …